
    
      The objective of this study is to perform a pilot study, offering referral to a genetic
      counseling and genetic testing for family members of a probands known to have a mutation in
      BRCA1 or BRCA2. In addition to BRCA1 and BRCA2, the NCCN suggests consideration of
      risk-reducing surgery for mutations in BRIP1, MSH2, MLH1, MSH6, PMS2, EPCAM, RAD51C, RAD51D,
      investigators will include these subjects as well in the study.
    
  